170 related articles for article (PubMed ID: 11284461)
21. Divalproex sodium in headache: literature review and clinical guidelines.
Silberstein SD
Headache; 1996 Oct; 36(9):547-55. PubMed ID: 8916563
[TBL] [Abstract][Full Text] [Related]
22. Divalproex in the treatment of migraine.
Freitag FG
Psychopharmacol Bull; 2003; 37 Suppl 2():98-115. PubMed ID: 15021865
[TBL] [Abstract][Full Text] [Related]
23. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
[TBL] [Abstract][Full Text] [Related]
24. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
[TBL] [Abstract][Full Text] [Related]
25. Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study.
Kochar DK; Garg P; Bumb RA; Kochar SK; Mehta RD; Beniwal R; Rawat N
QJM; 2005 Jan; 98(1):29-34. PubMed ID: 15625351
[TBL] [Abstract][Full Text] [Related]
26. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
Dodick DW; Turkel CC; DeGryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF;
Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
[TBL] [Abstract][Full Text] [Related]
27. Divalproex extended-release versus the original divalproex tablet: results of a randomized, crossover study of well-controlled epileptic patients with primary generalized seizures.
Thibault M; Blume WT; Saint-Hilaire JM; Zakhari R; Sommerville KW
Epilepsy Res; 2002 Aug; 50(3):243-9. PubMed ID: 12200215
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
[TBL] [Abstract][Full Text] [Related]
29. Cinnarizine and sodium valproate as the preventive agents of pediatric migraine: A randomized double-blind placebo-controlled trial.
Amanat M; Togha M; Agah E; Ramezani M; Tavasoli AR; Azizi Malamiri R; Fashandaky F; Heidari M; Salehi M; Eshaghi H; Ashrafi MR
Cephalalgia; 2020 Jun; 40(7):665-674. PubMed ID: 31707814
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study.
Shaygannejad V; Janghorbani M; Ghorbani A; Ashtary F; Zakizade N; Nasr V
Headache; 2006 Apr; 46(4):642-8. PubMed ID: 16643559
[TBL] [Abstract][Full Text] [Related]
31. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
32. Antiepileptic drugs in the prophylaxis of migraine, chronic headache forms and cluster headache: a review of their efficacy and tolerability.
D'Amico D
Neurol Sci; 2007 May; 28 Suppl 2():S188-97. PubMed ID: 17508169
[TBL] [Abstract][Full Text] [Related]
33. Anticonvulsant drugs for migraine prophylaxis.
Chronicle E; Mulleners W
Cochrane Database Syst Rev; 2004; (3):CD003226. PubMed ID: 15266476
[TBL] [Abstract][Full Text] [Related]
34. Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine.
Brandes JL; Smith T; Diamond M; Ames MH
Headache; 2007 Jun; 47(6):886-94. PubMed ID: 17578540
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies.
Mannix LK; Savani N; Landy S; Valade D; Shackelford S; Ames MH; Jones MW
Headache; 2007; 47(7):1037-49. PubMed ID: 17635595
[TBL] [Abstract][Full Text] [Related]
37. Treatment of chronic daily posttraumatic headache with divalproex sodium.
Packard RC
Headache; 2000 Oct; 40(9):736-9. PubMed ID: 11091292
[TBL] [Abstract][Full Text] [Related]
38. Comparing the Effects of Atorvastatin With Sodium Valproate (Divalproex) on Frequency and Intensity of Frequent Migraine Headaches: A Double-blind Randomized Controlled Study.
Hesami O; Sistanizad M; Asadollahzade E; Johari MS; Beladi-Moghadam N; Mazhabdar-Ghashghai H
Clin Neuropharmacol; 2018; 41(3):94-97. PubMed ID: 29746282
[TBL] [Abstract][Full Text] [Related]
39. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study.
Newman L; Mannix LK; Landy S; Silberstein S; Lipton RB; Putnam DG; Watson C; Jöbsis M; Batenhorst A; O'Quinn S
Headache; 2001 Mar; 41(3):248-56. PubMed ID: 11264684
[TBL] [Abstract][Full Text] [Related]
40. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]